![(E)-3-[3'-(4-Fluorophenyl)-1'-(1-methylethyl)-1H-indol-2-yl]-2-propnal CAS 93957-50-7](/images/load_icon.gif){kind=icon}
![(E)-3-[3'-(4-Fluorophenyl)-1'-(1-methylethyl)-1H-indol-2-yl]-2-propnal CAS 93957-50-7](/photo/pl184434197-e_3_3_4_fluorophenyl_1_1_methylethyl_1h_indol_2_yl_2_propnal_cas_93957_50_7.jpg)
Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 93957-50-7
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Bag,Drum
Delivery Time: 7-15 days
Payment Terms: L/C, D/A, T/T, Western Union
Supply Ability: TON
CAS NO:: |
93957-50-7 |
Appearance:: |
Yellow To Brown Powder Or Crystalline Powder |
Molecular Formula:: |
C20H18FNO |
Molecular Weight:: |
307.36100 |
EINECS NO:: |
425-370-4 |
MDL NO:: |
NA |
CAS NO:: |
93957-50-7 |
Appearance:: |
Yellow To Brown Powder Or Crystalline Powder |
Molecular Formula:: |
C20H18FNO |
Molecular Weight:: |
307.36100 |
EINECS NO:: |
425-370-4 |
MDL NO:: |
NA |
Product Description:
Product Name: (E)-3-[3'-(4"-Fluorophenyl)-1'-(1"-methylethyl)-1H-indol-2"-yl]-2-propnal CAS NO: 93957-50-7
Synonyms:
(E)-3-[3-(4-Fluorophenyl)-1-isopropylindol-2-yl]acrolein;
Fluvastatin sodiuM interMediate F2;
Fluorophenyl-1-Methylethyl-1H-indol-2-yl-(E)-2-propenal;
Chemical & Physical Properties:
Appearance: Yellow to brown powder or crystalline powder
Assay :≥99.0%
Density: 1.1
Boiling Point: 497.643℃ at 760 mmHg
Melting Point: 127-129℃
Flash Point: 254.766℃
Safety Information:
Safety Statements: S2-S22-S24-S37-S60-S61
HS Code: 2933990090
Risk Statements: R43; R50/53
Hazard Codes: Xi; N
Hazard Class: 9
Packing Group: III
(E)-3-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)acrylaldehyde is a reactant used in the synthesis of Fluvastatin, a synthetic HMG-CoA reductase inhibitor. Antilipemic.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
